World Class Dendritic Cell Therapy,Over 5000 Patients Treated,Award Winning Business
Laboratories Dr. Gansauge in Germany, providers of LANEX‑DC® Immunotherapy with dendritic cells, where future meets oncology.
{"hasPart": [{"@type": "Organization","name": "LDG Laboratories Dr. Gansauge GmbH","description": "We are award-winning Dendritic Cell Therapy (DCT) specialists in the heart of Germany.","achievement": [{"@type": "Achievement","name": "Over 5000 Patients Treated","description": "LDG Laboratories has successfully treated over 5000 patients in the past 20+ years."},{"@type": "Achievement","name": "Established Over 20 Years","description": "LDG Laboratories have been established for more than twenty years."},{"@type": "Achievement","name": "Five Published White Papers on DCT","description": "Our organisation has contributed five key white papers on Dendritic Cell Therapy (DCT) and published over 150 scientific papers in total."},{"@type": "Achievement","name": "65% Response Rate*","description": "Our internal evaluation showed stabilisation or improvement in the clinical course in around 65% of patients with advanced cancer treated with our LANEX‑DC® dendritic cell therapy. These figures are based on non-randomised observational data from a specific patient group and do not imply a general promise of success."}]}]}
Over 5000 Patients Treated
Established 20+ years.
Five Published White Papers on DCT
Over 150 published papers in total.
65% Response Rate*
Our internal evaluation showed stabilisation or improvement in the clinical course in around 65% of patients with advanced cancer treated with our LANEX‑DC® dendritic cell therapy.
These figures are based on non-randomised observational data from a specific patient group and do not imply a general promise of success. *see: LDG publications.
About Us
We are award-winning Dendritic Cell Therapy (DCT) specialists in the heart of Germany.
Led by world-renowned expert Prof. Dr. Frank Gansauge, we are at the forefront of medical innovation, providing fully regulated, end-to-end treatment with complete oversight from arrival to administration. With no outsourcing, and expert-led precision at every stage, we ensure unparalleled trust, reliability, and excellence in DCT care.
Effectiveness varies depending on individual factors such as tumour type, disease progression, overall condition, and immunological baseline. We are happy to offer personal advice on potential treatment options.
{"potentialAction": {"@type": "Action","name": "Check my suitability - Get in touch to explore whether DCT can help you.","target": "https://dendriticcelltherapybyldg.co.uk/contact.html"}}
Check my suitability
Would you like to know how Dendritic Cell Therapy may help treat your cancer?
{"hasPart": [{"@type": "MedicalTherapy","name": "Dendritic Cell Therapy (DCT)","therapyCategory": "Immunotherapy","description": "A personalized immunotherapy designed to train the immune system to recognize and destroy cancer cells naturally.","procedureType": {"@type": "MedicalProcedure","name": "Tailored Immunotherapy","description": "Step-by-step process including consultation, creation of dendritic cells, and targeted re-administration.","steps": [{"@type": "MedicalProcedureStep","name": "Step 1: Consultation","description": "A consultation with Professor Gansauge to assess your eligibility and draw blood."},{"@type": "MedicalProcedureStep","name": "Step 2: Laboratory Processing","description": "Processing blood to create dendritic cells in our advanced laboratory."},{"@type": "MedicalProcedureStep","name": "Step 3: Re-administration","description": "Re-administration of prepared dendritic cells to activate the immune system."}]}}]}
How it works
Tailored Immunotherapy.
Dendritic Cell Therapy (DCT) is an advanced immunotherapy designed to help your immune system recognise features unique to your tumour.
In our certified lab, we isolate immune cells from a small blood sample and process them to generate dendritic cells exposed to tumour-specific markers. After several days, these cells are returned to your bloodstream. This approach aims to support your immune system to detect and target previously unrecognised cancer-related markers.
Step 1
Consultation with Professor Gansauge in Berg. Blood is taken and a vitamin infusion is given. (approx. 2.5 hours)
Step 2
In our laboratory, dendritic cells are matured after being exposed to cancer-specific markers derived from your blood sample.
Step 3
The mature dendritic cells are administered through a simple injection into the skin of the abdominal area. This is typically followed by a supportive vitamin infusion. (approx. 2 hours)
Step 1
Consultation with Professor Gansauge in Berg. Blood is taken and a vitamin infusion is given. (approx. 2.5 hours)
Step 2
In our laboratory, dendritic cells are matured after being exposed to cancer-specific markers derived from your blood sample.
Step 3
The mature dendritic cells are administered through a simple injection into the skin of the abdominal area. This is typically followed by a supportive vitamin infusion. (approx. 2 hours)
Nestled in the peaceful town of Berg on the shores of the renowned Lake Starnberg — just 30 minutes from Munich — our clinic, the exclusive location for our services, offers a calm and welcoming environment designed to promote your well-being.
","image": "https://dendriticcelltherapybyldg.co.uk/cmsUploads/facilitiesSlides/images/IMG_4973-1.jpg"},{"@type": "MedicalClinic","name": "Expert Team. Personalised Care.","description": "
At LDG, your treatment is guided by a team of highly experienced specialists in immunology, oncology, and cell therapy. Each patient benefits from a personalised consultation with Prof. Dr. Frank Gansauge, a world-renowned expert in dendritic cell therapy and medical director of LDG.
","image": "https://dendriticcelltherapybyldg.co.uk/cmsUploads/facilitiesSlides/images/frank_consultation_v2.png"},{"@type": "MedicalClinic","name": "Our Own State-of-the-Art Laboratory","description": "
We operate a cutting-edge, GMP-certified laboratory exclusively for LDG patients. This guarantees the highest standards of safety, precision, and personalised care throughout the entire treatment process.
","image": "https://dendriticcelltherapybyldg.co.uk/cmsUploads/facilitiesSlides/images/frankPressingButton.jpg"},{"@type": "MedicalClinic","name": "Fresh Cells. Maximum Integrity.","description": "
At LDG, our highest priority is to administer fresh, non-frozen dendritic cells—delivered directly from our GMP-certified laboratory to our clinic for optimal cell viability and immune activation.
We operate a cutting-edge, GMP-certified laboratory exclusively for LDG patients. This guarantees the highest standards of safety, precision, and personalised care throughout the entire treatment process.
Fully regulated over 600 m² facility, government-approved for stringent quality control.
Complete in-house oversight – every stage of your treatment is managed by our expert team.
Exclusively for LDG patients – ensuring a truly personalised and secure therapeutic experience.
Nestled in the peaceful town of Berg on the shores of the renowned Lake Starnberg — just 30 minutes from Munich — our clinic, the exclusive location for our services, offers a calm and welcoming environment designed to promote your well-being.
Serene, discreet atmosphere for a relaxed and stress-free experience.
Attentive and professional staff committed to your personal care.
Private consultation rooms outfitted with advanced medical technology to enable efficient, same-day diagnostics and evaluations.
Expert Team. Personalised Care.
At LDG, your treatment is guided by a team of highly experienced specialists in immunology, oncology, and cell therapy. Each patient benefits from a personalised consultation with Prof. Dr. Frank Gansauge, a world-renowned expert in dendritic cell therapy and medical director of LDG.
Multidisciplinary team of medical and scientific experts dedicated to your care.
Personal consultation with Prof. Dr. Gansauge as part of your tailored treatment plan.
From your first visit, your recovery is supported by in-house professionals—nothing is outsourced.
At LDG, our highest priority is to administer fresh, non-frozen dendritic cells—delivered directly from our GMP-certified laboratory to our clinic for optimal cell viability and immune activation.
Whenever medically feasible, we provide freshly prepared dendritic cells.
In rare cases—such as unforeseen delays in a patient’s return to the clinic or urgent health-related scheduling changes—we offer the option to cryopreserve cells temporarily, ensuring treatment remains possible upon return.
Thanks to our own temperature-controlled transport system, the integrity of the cells is maintained at every step. The journey from our laboratory to the clinic takes just 1.5 hours.
Our promise: If it’s possible for the patient, we always provide fresh dendritic cells.
{"hasPart": {"@type": "CreativeWork","name": "The Potential of Dendritic Cell Therapy","description": "Who May Benefit from Treatment with Dendritic Cells?","image": "https://dendriticcelltherapybyldg.co.uk/assets/img/photos/2K3A5615.jpg","url": "https://dendriticcelltherapybyldg.co.uk/cancer-and-dct.html#when-is-dendritic-cell-therapy-effective"}}
Information
The Potential of Dendritic Cell Therapy
Who May Benefit from Treatment with Dendritic Cells?
Dendritic Cell Therapy (DCT) is a personalised immunotherapeutic approach that may be considered for patients of various ages and with different types of cancer. It is less invasive than surgery, radiotherapy, or chemotherapy, and can often be integrated alongside conventional cancer treatments.
At LDG, DCT is generally well tolerated and has shown promising results in clinical application. Based on internal observational data, we have seen positive immune responses and stabilisation of disease in approximately 60–65% of treated cases. Individual outcomes may vary depending on tumour type, disease stage, and the patient’s overall health and immune status.
{"hasPart": [{"@type": "ItemList","name": "We are Innovators","itemListElement": [{"@type": "CreativeWork","name": "LANEX-DC®","description": "Over 5,000 successful therapies with LANEX-DC®. Our DCT treatments are only used for our own patients.","url": "https://dendriticcelltherapybyldg.co.uk/medical-board.html"},{"@type": "CreativeWork","name": "White Papers","description": "5 white papers and over 150 papers published to date.","url": "https://dendriticcelltherapybyldg.co.uk/publications-and-research.html"},{"@type": "CreativeWork","name": "Advanced laboratory","description": "One of only three government-regulated dendritic cell laboratories in Europe — fully owned and operated by LDG.","url": "https://dendriticcelltherapybyldg.co.uk/treatment-facilities.html"}]}]}
What We Do
We are Innovators
LANEX-DC®
Over 5,000 successful therapies with LANEX-DC®. Our DCT treatments are only used for our own patients.
White Papers
5 white papers and over 150 papers published to date.
Advanced laboratory
One of only three government-regulated dendritic cell laboratories in Europe — fully owned and operated by LDG.
{"hasPart": [{"@type": "MedicalTherapy","name": "Could DCT work for me?","description": "Dendritic Cell Therapy (DCT) is a personalised and well-tolerated form of immunotherapy that may be considered for patients with various types of cancer and across different age groups.","therapyCategory": "Immunotherapy","potentialAction": {"@type": "Action","name": "Could DCT work for me? Contact us or book a consultation to find out more.","target": "https://dendriticcelltherapybyldg.co.uk/contact.html"}}]}
Check my suitability
Could DCT work for me?
Dendritic Cell Therapy (DCT) is a personalised and well-tolerated form of immunotherapy that may be considered for patients with various types of cancer and across different age groups.
{"hasPart": {"@type": "ItemList","name": "Patient Stories","description": "Learn about the experience had by some of our previous patients.","itemListElement": [{"@type": "VideoObject","name": "What can you expect from Dendritic Cell Therapy?","description": "
Dendritic Cell Therapy (DCT) is a personalised approach that aims to activate the body's immune response against cancer. Based on internal observational data at LDG, we have seen signs of clinical stabilisation or positive immune response in approximately 60–65% of treated cases.
","thumbnailUrl": "https://dendriticcelltherapybyldg.co.uk/cmsUploads/informationSlides/images/thumbs/drfrank-1.jpg","embedUrl": "https://vimeo.com/1047367964","@id": "https://vimeo.com/1047367964","transcript": "So what can we expect from a dendritic cell therapy? Dendritic cell therapy is highly effective. We have response rates between 60 and 65% according to oncologic criteria. We have-- we can avoid relapses in the adjuvant situation.
Anyhow, uh, this is not... a promise for healing, although we have complete remissions and we have a lot of partial responses of the patient and a lot of patients tumor-free after dendritic cell therapy in the adjuvant situation.
So we can classify the dendritic cell therapy as a very new, very highly effective therapy with very few side effects."},{"@type": "VideoObject","name": "Frank explains how DCT can be seen as the fourth pillar of cancer therapy.","description": "
Dendritic Cell Therapy extends the three classical cancer treatments of surgery, chemotherapy and radiation therapy.
","thumbnailUrl": "https://dendriticcelltherapybyldg.co.uk/cmsUploads/informationSlides/images/thumbs/Screenshot_2025-01-24_at_14.png","embedUrl": "https://vimeo.com/1047193532","@id": "https://vimeo.com/1047193532","transcript": "Well, in... in the cancer therapy, we're always talking about the three columns, which is surgery, chemotherapy, and radiation therapy.
These are the classical three columns. Immune therapy, whether it's now dendritic cell therapy or also antibody therapy, which is also quite new, uh, in the... in the treatment of cancers, this is called the fourth column.
Where will it lead us? Well, hopefully, it leads us to have another good tool in fighting cancer, uh, and improve our, uh, survi- the survival rates in cancer patients that they have better responding, in combination of all these four columns, to their cancer, and avoid relapses in cancer patients."},{"@type": "VideoObject","name": "Who is my consultation with and is there any follow up?","description": "
In this short video Frank summarises the consultation process.
","thumbnailUrl": "https://dendriticcelltherapybyldg.co.uk/cmsUploads/informationSlides/images/thumbs/Screenshot_2025-01-24_at_14-2.png","embedUrl": "https://vimeo.com/1047418372","@id": "https://vimeo.com/1047418372","transcript": "With regards to who will be the doctor treating you and how is my follow-up as a patient afterwards.
Well, Zoom calls or personal consultations are, in 99% of the cases, made by me.
And the follow-up is quite easy.
Patients do not have to come to Germany to make their follow-up because every patient is in a follow-up program anyhow from his treating doctors in his home country.
And it's turned out to be very effective that the patient send me their medical reports when they had examinations, uh, by email or even if it's, uh, bigger data volume, like CTs or MRIs, you also can transfer, uh, WeTransfer to me, and then I can have an online consultation with the patient again, either by Zoom or either by, uh, email."}]}}
Information
"DCT is new and highly effective therapy with very few side effects"
What can you expect from Dendritic Cell Therapy?
Dendritic Cell Therapy (DCT) is a personalised approach that aims to activate the body's immune response against cancer. Based on internal observational data at LDG, we have seen signs of clinical stabilisation or positive immune response in approximately 60–65% of treated cases.
{"hasPart": [{"@type": "CreativeWork","name": "Achievements","description": "We're proud of our achievements","achievement": [{"@type": "Achievement","name": "Over 5000 Patients Treated","description": "LDG Laboratories has successfully treated over 5000 patients in the past 20+ years."},{"@type": "Achievement","name": "Established Over 20 Years","description": "LDG Laboratories have been established for more than twenty years."},{"@type": "Achievement","name": "Three Time German Business Award Winner","description": "LDG Laboratories have won the German Business Awards three times."}]}]}
About Us
We're proud of our achievements
5000
Over 5000 Patients Treated
20
Established Over 20 Years
3
Three Time German Business Award Winner
{"hasPart": [{"@type": "CreativeWork","name": "Dendritic Cell Therapy Alongside Traditional Therapies","description": "DCT can be effectively combined with traditional cancer treatments like chemotherapy, immunotherapy, and radiotherapy to enhance overall treatment outcomes."},{"@type": "MedicalTherapy","name": "Chemotherapy","description": "DCT works synergistically with chemotherapy and can typically be integrated into your treatment cycle with minimal disruption."},{"@type": "MedicalTherapy","name": "Immunotherapy","description": "Both immunotherapy and DCT aim to stimulate the immune system. When used together, they can create a stronger, more sustained anti-cancer response."},{"@type": "MedicalTherapy","name": "Radiotherapy","description": "Radiotherapy and DCT work well together, as radiation helps expose tumours to the immune system, increasing DCT’s effectiveness."}]}
Information
Dendritic Cell Therapy Alongside Traditional Therapies
DCT can be effectively combined with traditional cancer treatments like chemotherapy, immunotherapy, and radiotherapy to enhance overall treatment outcomes.
Frank explains how DCT is compatible with chemotherapy.
Chemotherapy
DCT works synergistically with chemotherapy and can typically be integrated into your treatment cycle with minimal disruption.
No, blood can be taken one week after treatment, and DCT cells can be injected up to the day before your next cycle.
No, chemotherapy targets dividing cells, while dendritic cells are fully matured and no longer dividing, making them unaffected. This is backed up by our own research.
Reduces Side Effects – By stimulating immune function, DCT may help patients recover faster from chemotherapy-induced immune suppression.
Enhances Immune Recovery – While chemotherapy weakens the immune system, DCT helps restore and strengthen immune function by training it to recognise and attack cancer cells.
Both immunotherapy and DCT aim to stimulate the immune system. When used together, they can create a stronger, more sustained anti-cancer response.
No DCT can be administered alongside immunotherapy.
No, they work together, enhancing the immune system’s ability to fight cancer.
Creates a More Potent Immune Response. DCT helps prime T-cells, making other immunotherapies more effective in attacking cancer.
Boosts the Effectiveness of Checkpoint Inhibitors. DCT can enhance response to PD-1/PD-L1 and CTLA-4 inhibitors by increasing the number of tumour-targeting immune cells.
Radiotherapy and DCT work well together, as radiation helps expose tumours to the immune system, increasing DCT’s effectiveness.
No, in fact, the opposite is true, radiation exposes tumour antigens, allowing dendritic cells to recognise and present them more effectively to the immune system
Targets hidden cancer cells – Radiation exposes tumour antigens, which DCT-trained immune cells can then identify and attack.
Enhances the Abscopal Effect – This means that when radiation targets one tumour, the immune system (activated by DCT) can attack cancer cells in distant areas of the body.
Supports recovery & reduces inflammation. DCT may help the immune system heal damaged tissues and reduce side effects from radiation.
{"hasPart": {"@type": "ItemList","name": "Testimonials","description": "See what our patients are saying about us.","itemListElement": [{"@type": "Review","position": 0,"author": {"@type": "Person","name": "Wendy"},"reviewBody": "Everything seems to be working and my cancer is stable... I’m very happy with the results.","reviewRating": {"@type": "Rating","ratingValue": "5","bestRating": "5"},"associatedMedia": {"@type": "VideoObject","name": "Testimonial from Wendy","thumbnailUrl": "https://dendriticcelltherapybyldg.co.uk/cmsUploads/testimonials/images/thumbs/wendy_testimonial_screenshot.jpg","contentUrl": "https://vimeo.com/1052107674","transcript": "So I-- my experience of being treated, treated with Frank is-- been an interesting one, and an amazing experience.
I have been a patient of his for about two years now, and I am very happy with everything that he has done and the clinic has done for me.
And everything seems to be working, and my cancer is stable, and for as long as that happens, I'm going to keep coming back for more treatment because I find that it's an amazing service w- that I don't have in my own country. So I'm very happy, very happy with the results."}},{"@type": "Review","position": 1,"author": {"@type": "Person","name": "Matt"},"reviewBody": "In my case I do feel that DCT has greatly improved my outcomes.","reviewRating": {"@type": "Rating","ratingValue": "5","bestRating": "5"},"associatedMedia": {"@type": "VideoObject","name": "Testimonial from Matt","thumbnailUrl": "https://dendriticcelltherapybyldg.co.uk/cmsUploads/testimonials/images/thumbs/matt_testimonial_screenshot-1.jpg","contentUrl": "https://vimeo.com/1052109910","transcript": "In my case, I do feel that DCT has greatly improved my outcomes.
Um, I have not stopped taking chemo because I am believing that the combination of DCT with the chemo, under the advice of Frank, is the way to go.
And I have had good results with this."}}]}}
Testimonials
See what our patients are saying about us.
Matt
“In my case I do feel that DCT has greatly improved my outcomes.”
{"hasPart": [{"@type": "CreativeWork","name": "Suitable for the Young and the Young at Heart","description": "Dendritic Cell Therapy (DCT) is a gentle and individualised form of immunotherapy that may be considered as a treatment option for patients of all ages, including both children and adults.","hasPart": [{"@type": "CreativeWork","name": "Personalised Care","description": "Our treatment plans are carefully tailored to meet the specific needs of both younger and older patients, with a strong focus on comfort, safety, and individual support throughout the therapy process."},{"@type": "CreativeWork","name": "Gentle, Immune-Based Approach","description": "Dendritic Cell Therapy (DCT) is designed to work in harmony with the body’s natural immune response. As a well-tolerated, non-aggressive form of immunotherapy, it may offer an alternative to conventional treatments, particularly for patients seeking a gentler therapeutic option. "}]}]}
Information
Suitable for the Young and the Young at Heart
Dendritic Cell Therapy (DCT) is a gentle and individualised form of immunotherapy that may be considered as a treatment option for patients of all ages, including both children and adults.
At LDG, our team is experienced in caring for patients across generations. We place great importance on creating a supportive, age-appropriate environment that promotes comfort, understanding, and trust throughout the entire treatment journey.
Personalised Care
Our treatment plans are carefully tailored to meet the specific needs of both younger and older patients, with a strong focus on comfort, safety, and individual support throughout the therapy process.
Gentle, Immune-Based Approach
Dendritic Cell Therapy (DCT) is designed to work in harmony with the body’s natural immune response. As a well-tolerated, non-aggressive form of immunotherapy, it may offer an alternative to conventional treatments, particularly for patients seeking a gentler therapeutic option.
{"hasPart": {"@type": "ItemList","name": "Publications","description": "Read our research into the effectiveness of DCT","itemListElement": [{"@type": "ScholarlyArticle","position": 0,"name": "Effectivity of Long Antigen Exposition Dendritic Cell Therapy (LANEX-DC®)","headline": "in the Palliative Treatment of Pancreatic Cancer","author": {"@type": "Person","name": "F. Gansauge, B. Poch, R. Kleef, and M. Schwarz"},"publisher": {"@type": "Organization","name": "Bentham Science Publishers"},"datePublished": "2013-12-01","url": "https://dendriticcelltherapybyldg.co.uk/cmsUploads/publication/files/Effectivity_of_Long_Antigen_Exposition_Dendritic_Cell_Therapy_PancreaticCancer_publication.pdf"},{"@type": "ScholarlyArticle","position": 1,"name": "Evaluation of long antigen exposition dendritic cell therapy (LANEX-DC®)","headline": "in the Adjuvant Treatment of Pancreatic Cancer – Results of a Single Center Analysis","author": {"@type": "Person","name": "Frank Gansauge and Bertram Poch"},"publisher": {"@type": "Organization","name": "HSPC (Heighten Science Publications Corporation)"},"datePublished": "2022-07-25","url": "https://dendriticcelltherapybyldg.co.uk/cmsUploads/publication/files/Evaluation_of_long_Antigen_exposition_dendritic_cell_therapy_PancreaticCancer_publication.pdf"},{"@type": "ScholarlyArticle","position": 2,"name": "Effectivity on Long Antigen Exposition Dendritic Cell Therapy (LANEX-DC®)","headline": "in the Adjuvant Treatment of Gastric Cancer","author": {"@type": "Person","name": "Frank Gansauge and Bertram Poch"},"publisher": {"@type": "Organization","name": "Remedy Publications LLC"},"datePublished": "2022-07-04","url": "https://dendriticcelltherapybyldg.co.uk/cmsUploads/publication/files/Effectivity_of_Long_Antigen_Exposition_Dendritic_Cell_Gastric_Cancer_publication.pdf"},{"@type": "ScholarlyArticle","position": 3,"name": "Additional Long Antigen Exposition Dendritic Cell Therapy (LANEX-DC®)","headline": "in the Palliative Treatment of Stage IV Colorectal Cancer Patients","author": {"@type": "Person","name": "Frank Gansauge, Thea Hamma, Helga Bach, Bertram Poch"},"publisher": {"@type": "Organization","name": "Remedy Publications LLC."},"datePublished": "2022-07-23","url": "https://dendriticcelltherapybyldg.co.uk/cmsUploads/publication/files/Additional_Long_Antigen_Exposition_Dendritic_Cell_publication.pdf"},{"@type": "ScholarlyArticle","position": 4,"name": "Dendritic Cell Therapy","headline": "in the palliative Treatment of Pancreatic Cancer Patients","author": {"@type": "Person","name": "Frank Gansauge and Bertram Poch"},"publisher": {"@type": "Organization","name": "European Society of Medicine"},"datePublished": "2022-12-31","url": "https://dendriticcelltherapybyldg.co.uk/cmsUploads/publication/files/pancreatic_cancer_palliative_2022_publication.pdf"}]}}
Publications
Read our research into the effectiveness of DCT
Explore our published research on the effectiveness of Dendritic Cell Therapy (DCT) in cancer treatments, including studies on LANEX‑DC® therapy.
{"hasPart": {"@type": "FAQPage","name": "Getting to Berg","description": "To get to Berg you can fly, take the train, or go by road.","mainEntity": [{"@type": "Question","name": "How can I get to Berg By Air?","acceptedAnswer": {"@type": "Answer","text": "Easy International Access"}},{"@type": "Question","name": "How can I get to Berg By Train?","acceptedAnswer": {"@type": "Answer","text": "Connected by Europe’s Rail Network"}},{"@type": "Question","name": "How can I get to Berg By Road?","acceptedAnswer": {"@type": "Answer","text": "Comfortable Access by Car"}},{"@type": "Question","name": "How can I get to Berg By Taxi?","acceptedAnswer": {"@type": "Answer","text": "Private Transfers for a Smooth Arrival"}}]}}
Our Location
Our clinic is located in Berg, just 30 minutes from Munich.
You can reach us easily by air, rail, or road.
By Air
Easy International Access
By Train
Connected by Europe’s Rail Network
By Road
Comfortable Access by Car
By Taxi
Private Transfers for a Smooth Arrival
{"hasPart": [{"@type": "Place","name": "About Berg","description": "Berg is a municipality in the district of Starnberg in Bavaria, Germany, on the shore of the Starnberg Lake. It is most famous for the royal Berg Castle.","address": {"@type": "PostalAddress","addressLocality": "Berg","addressRegion": "Bavaria","addressCountry": "Germany"},"geo": {"@type": "GeoCoordinates","latitude": 47.9504,"longitude": 11.3649},"containsPlace": [{"@type": "TouristAttraction","name": "History of Berg","description": "Potted history of Berg from the 800's to 2000's","url": "/about-berg/history-of-berg.html"},{"@type": "TouristAttraction","name": "Places to Visit","description": "Places to Visit in Berg, Bavaria","url": "/about-berg/places-to-visit.html"},{"@type": "TouristAttraction","name": "Lakes & Mountains","description": "Lakes and Mountains Around Berg, Bavaria","url": "/about-berg/lakes-and-mountains.html"},{"@type": "TouristAttraction","name": "Shopping","description": "Shopping in and Around Berg, Bavaria","url": "/about-berg/shopping.html"},{"@type": "TouristAttraction","name": "Culture","description": "Cultural Experiences in and Around Berg, Bavaria","url": "/about-berg/culture.html"}]}]}
Our Location
About Berg
Berg is a municipality in the district of Starnberg in Bavaria, Germany, on the shore of the Starnberg Lake. It is most famous for the royal Berg Castle.
